Hyperhidrosis

Hyperhidrosis is a highly treatable disorder that involves the over-activity of sweat glands under the arms (axillae) and on the palms of the hands and soles of the feet. An estimated 4.8% of individuals in the United States – around 15.3 million persons – have hyperhidrosis (Doolittle et al, 2016).

Hyperhidrosis occurs when muscles and tendon sheaths spasm, causing nearby glands to become overactive. 

Physicians often use neuromodulator injections to reduce this spasticity, because the medicine relaxes muscles, limiting the sweat gland activity by almost seventy percent. The procedure is quick, and patients generally do not complain of significant discomfort. Results appear within five to ten days and last up to twelve months after treatment.

Neuromodulators last longer in this particular area because they are administered in larger doses than for typical cosmetic treatments. In the axillae (underarm) area, the medicine is introduced in small muscle and tendon sheaths. Since these muscles are used less frequently than facial muscles, treatment benefits endure longer.  Other areas, such as the soles of the feet and the palms of the hands, require greater doses of medicine and have shorter-lasting results.

Other therapies for hyperhidrosis include topical aluminum chloride and certain anti-cholinergic therapies.

Should you experience excessive sweating, please feel free to contact our clinic for a consultation to review your options. 

References

Doolittle, J., Walker, P., Mills, T. et al. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res 308, 743–749 (2016). https://doi.org/10.1007/s00403-016-1697-9

Hyperhidrosis is a highly treatable disorder that involves the over-activity of sweat glands under the arms (axillae) and on the palms of the hands and soles of the feet. An estimated 4.8% of individuals in the United States – around 15.3 million persons – have hyperhidrosis.

Hyperhidrosis occurs when muscles and tendon sheaths spasm, causing nearby glands to become overactive. Physicians use neuromodulator injections to reduce this spasticity because the medicine relaxes muscles under the axillae, limiting the sweat gland activity by almost seventy percent. The procedure is quick, and patients generally do not complain of significant discomfort. Results appear within five to ten days and last up to twelve months after treatment.

Neuromodulators last longer in this particular area because they are administered in larger doses than for typical cosmetic treatments. In the axillae (underarm) area, the medicine is introduced in small muscle and tendon sheaths. Since these muscles are used less frequently than facial muscles, treatment benefits endure longer.  Other areas, such as the soles of the feet and the palms of the hands, require greater doses of medicine and have shorter-lasting results.

Other therapies for hyperhidrosis include topical aluminum chloride and certain anti-cholinergic therapies.

Should you experience excessive sweating, please feel free to contact our clinic for a consultation to review your options. 



References

Doolittle, J., Walker, P., Mills, T. et al. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res 308, 743–749 (2016). https://doi.org/10.1007/s00403-016-1697-9